| Term es nes pval sidak fdr geneset_size leading_edge leading_edge_size |
| Inclusion body myositis 0.9487094639311724 4.024052576436688 5.720513742080158e-05 0.0335758320589648 0.0010044549129476 2 P05067 1 |
| Nodlike receptor nlr signaling pathway 0.887160820648579 3.737747647862917 0.0001856761687435 0.1049350244767057 0.0020821534421547 2 Q9Y6K9 1 |
| Canonical nfkb pathway 0.887160820648579 3.737747647862917 0.0001856761687435 0.1049350244767057 0.0020821534421547 2 Q9Y6K9 1 |
| Altered glycosylation of muc1 in tumor microenvironment 0.887160820648579 3.737747647862917 0.0001856761687435 0.1049350244767057 0.0020821534421547 2 Q9Y6K9 1 |
| Fibrin complement receptor 3 signaling pathway 0.8874544852697661 3.3365394016181504 0.0008482840348777 0.3974836558311382 0.0077911625972622 3 P61586,Q9Y6K9 2 |
| Supression of hmgb1 mediated inflammation by thbd 0.878517047335321 3.2957637552959724 0.000981545177098 0.4436013488521045 0.008744766368395 3 Q9Y6K9,O15111 2 |
| Arachidonate epoxygenase epoxide hydrolase 0.7954996690933176 3.291188196353164 0.0009976514590452 0.4489309821219403 0.008744766368395 2 P20674 1 |
| Neuroinflammation 0.8403459181288175 3.119202145053095 0.0018134150326183 0.6616219685745179 0.0144347836596419 3 P00403 1 |
| Monoamine transport 0.7571144937127787 3.0963615891297898 0.0019591130023415 0.6898619136631274 0.0153893481894459 2 P49815 1 |
| Photodynamic therapyinduced nfe2l2 nrf2 survival signaling 0.9027887357165968 3.0414162837326906 0.002354680344442 0.7552215607949317 0.0177942299447079 4 P07099 1 |
| Nephrogenesis 0.7392455327597653 3.0039890085183796 0.0026646495138837 0.7966687769492684 0.0191041353828244 2 O95747 1 |
| Glycerolipids and glycerophospholipids 0.7931165862620349 2.895136555110152 0.0037899362311084 0.8963660534497332 0.02470534467736 3 Q9HCL2 1 |
| Cholesterol metabolism with bloch and kandutschrussell pathways 0.6843704249836429 2.888806033063102 0.0038670753047318 0.9010478964508292 0.024824128569085 21 P48449,P49327,O95864,Q16850,Q9BWD1,Q15392,Q15125,Q15800,Q14739 9 |
| Sting pathway in kawasakilike disease and covid19 0.7892458455725764 2.8764893243636203 0.0040212579766381 0.9097824127466244 0.0252780664061027 3 Q9Y6K9 1 |
| Apoptosis modulation by hsp70 0.7657347338942757 2.762279357825892 0.0057399343052444 0.9678265342090484 0.0337940418826325 3 O95831 1 |
| Striated muscle contraction pathway 0.9075451955893268 2.7612103347346095 0.005758757543361 0.9681881260673134 0.0337940418826325 5 P09493,P08670,P67936 3 |
| Familial hyperlipidemia type 5 0.6929185969556635 2.7593388818288216 0.0057918439333706 0.9688139057094568 0.0337940418826325 2 Q9UBV2 1 |
| Familial hyperlipidemia type 1 0.6929185969556635 2.7593388818288216 0.0057918439333706 0.9688139057094568 0.0337940418826325 2 Q9UBV2 1 |
| Nad metabolism 0.7634049132366523 2.750872583737693 0.0059436757080006 0.9715316280190092 0.0337940418826325 3 P43490 1 |
| Nad biosynthetic pathways 0.7634049132366523 2.750872583737693 0.0059436757080006 0.9715316280190092 0.0337940418826325 3 P43490 1 |
| Mapk and nfkb signaling pathways inhibited by yersinia yopj 0.7555398417283947 2.712245376642045 0.0066829102195504 0.9817408415170362 0.0366027284501984 3 Q9Y6K9 1 |
| Mitochondrial complex ii assembly 0.6793514228987481 2.686241159431395 0.007226091242269 0.9868276923911884 0.0381412598246366 2 P31040 1 |
| Ovarian infertility 0.7411589341351386 2.6411359797141976 0.0082628548250074 0.9929407559934904 0.0414531456347011 3 Q8WXH0 1 |
| Neovascularisation processes 0.6628060886829972 2.5961877970707183 0.0094264528043477 0.9964975211344388 0.0461278059360294 2 P28482 1 |
| Mitochondrial fatty acid synthesis pathway 0.7245945051307516 2.5584515466783513 0.0105139470944402 0.9981820697524846 0.0506195678659742 3 Q8IVS2,Q53GQ0 2 |
| Nad metabolism sirtuins and aging 0.7098682397030625 2.4842369913169913 0.0129829372825085 0.9995909067731876 0.0582767936665985 3 P43490 1 |
| Angiotensin ii receptor type 1 pathway 0.7077126779212153 2.4733177974035634 0.0133865044544894 0.9996795281529356 0.0596398743233595 3 Q06124,P63244 2 |
| Eicosanoid metabolism via lipooxygenases lox 0.8926372573905879 2.423225609996784 0.0153833696349905 0.9999043910410484 0.0670355596502872 6 O15254,Q8N8N7,Q14914 3 |
| Vitamin d metabolism 0.6951340615690135 2.4093134385295856 0.015982565085655 0.9999335235770814 0.0691419663488122 3 Q9UBM7,P38435 2 |
| Familial hyperlipidemia type 4 0.6931479642502373 2.399162751303539 0.0164326091284188 0.9999494104663876 0.069452536981284 3 P49327,Q9UBV2 2 |
| Triacylglyceride synthesis 0.7572847682119126 2.383565217149803 0.0171458461110169 0.999967192037568 0.0710838203352579 4 O00116,Q99943,Q9HCL2 3 |
| Antiviral and antiinflammatory effects of nrf2 on sarscov2 pathway 0.8185615017529635 2.379743821125337 0.0173246775091793 0.9999705693528744 0.0713298791240003 5 P09601,Q9Y6K9 2 |
| Metabolism of spingolipids in er and golgi apparatus 0.6876874739226145 2.371191934255653 0.0177308208690682 0.999977005771954 0.0720088439376447 3 Q10472 1 |
| Onecarbon metabolism and related pathways 0.6816277075442696 2.3662516829051774 0.0179692240606317 0.9999801077578072 0.0720588384088134 14 O43865,P34896,P04818,O15382,P35790,P00390,P32929 7 |
| Eicosanoid synthesis 0.6105228325612251 2.3049355051028497 0.021170185757892 0.9999971673567354 0.0836993436917985 2 Q9H7Z7 1 |
| Nocgmppkg mediated neuroprotection 0.8316763738994788 2.2811930266531144 0.0225370272200973 0.9999987700484844 0.0879385964078307 7 P30536 1 |
| Eicosanoid metabolism via cyclooxygenases cox 0.8560440418544618 2.2725870304549733 0.0230510779362871 0.9999991015389562 0.0891858868288886 6 O15254,Q8N8N7,Q14914 3 |
| Hypothesized pathways in pathogenesis of cardiovascular disease 0.6630254882489258 2.2437131894526563 0.024850860939529 0.9999997011784774 0.0934113429494498 3 P21333,P28482 2 |
| Cannabinoid receptor signaling 0.6630254882489217 2.243713189452636 0.0248508609395303 0.9999997011784774 0.0934113429494498 3 P10644,P28482 2 |
| Regulation of wnt bcatenin signaling by small molecule compounds 0.6623634558093323 2.2402651978543764 0.0250737111992371 0.9999997392925676 0.0934113429494498 3 Q07954,P48729 2 |
| Heart development 0.6623634558093303 2.2402651978543693 0.0250737111992376 0.9999997392925676 0.0934113429494498 3 Q06124,P28482 2 |
| Dna mismatch repair 0.6167444768202145 2.2257003327541542 0.0260342604653645 0.99999985526381 0.0947710579135524 18 P28340,Q9NR33,Q9UQ84,P41440,Q9NRF9,P35250 6 |
| Hair follicle development cytodifferentiation part 3 of 3 0.5946393117141043 2.2144260985282416 0.0267994812178877 0.9999999094700948 0.0963812667896325 2 P35222 1 |
| Joubert syndrome 0.6447295293298397 2.2101561353409855 0.0270943280763418 0.9999999244509574 0.0968581668357848 15 P09874,P21333,O43924,Q9Y4I1,P61586,Q10713 6 |
| Influence of laminopathies on wnt signaling 0.758211447431147 2.1977572944663715 0.0279664062114892 0.9999999557695964 0.0993806220729708 9 O60725 1 |
| Hostpathogen interaction of human coronaviruses autophagy 0.7158121881608396 2.1861582823157972 0.0288040271990515 0.999999973563552 0.1008759863638767 4 Q99570 1 |
| Mammary gland development pathway pregnancy and lactation stage 3 of 4 0.774629726405501 2.184927991730531 0.028894126747442 0.9999999749879837 0.1008759863638767 5 P06753 1 |
| Microglia pathogen phagocytosis pathway 0.6501158556769182 2.176233949018625 0.0295377716067841 0.9999999831637196 0.1025235444723845 3 O15143,O00443 2 |
| Sterol regulatory elementbinding proteins srebp signaling 0.53845129304839 2.1383237334377334 0.0324904776100312 0.9999999972698712 0.1102091768931172 25 Q8WTV0,P55735,P48449 3 |
| Progeriaassociated lipodystrophy 0.7424759288675618 2.1229069559281752 0.0337616494591024 0.9999999987545976 0.1137834640261338 9 P09874,O75531,P46063,O60725,O75844 5 |
| Base excision repair 0.6553143150960876 2.1209573951834537 0.0339253879340901 0.9999999988744376 0.1137834640261338 12 P27695,P09874,P28340,Q9NR33,P09429,Q9NRF9 6 |
| Oxidation by cytochrome p450 0.7574596490210304 2.107625641399219 0.0350633838266587 0.999999999443102 0.1156510505221838 5 Q16850 1 |
| Vitamin a and carotenoid metabolism 0.7498092684755312 2.0729751361474924 0.0381745935826027 0.999999999919005 0.1245367889006221 5 Q8WTV0 1 |
| Ferroptosis 0.5380435338117266 2.020688033238859 0.0433120693830664 0.9999999999966898 0.1397692184956251 23 Q6P1A2,P45880,Q15365,P09601,Q15043,P32929 6 |
| Mirna biogenesis 0.6176762661370376 2.0044314604241222 0.0450238620706673 0.9999999999988636 0.1445120734203677 3 Q9HAV4,P62826 2 |
| Familial partial lipodystrophy fpld 0.766302233905401 1.9948431830712263 0.0460599859046544 0.9999999999994056 0.1462649552397803 7 O60725,O75844,O75531 3 |
| Insulin signaling in adipocytes diabetic condition 0.6751442378834783 1.9883073334675705 0.046777710230687 0.9999999999996207 0.1467678990301716 4 P31751 1 |
| Insulin signaling in adipocytes normal condition 0.6751442378834783 1.9883073334675705 0.046777710230687 0.9999999999996207 0.1467678990301716 4 P31751 1 |
| 7oxoc and 7betahc pathways 0.71369318073918 1.9844855591032509 0.0472017363715124 0.9999999999997092 0.1467678990301716 9 P61916,Q9UBM7,Q15125,O15118 4 |
| Relationship between inflammation cox2 and egfr 0.6632450331125745 1.9296408512374792 0.053651353452838 0.999999999999995 0.1651023608832179 4 Q9H7Z7,P31751,P28482 3 |
| Foxa2 pathway 0.6014564713670899 1.9173586994248992 0.0551923773449891 0.999999999999998 0.1681114758926455 3 P49327,Q13085 2 |
| Methionine metabolism leading to sulfur amino acids and related disorders 0.7151055660409285 1.9142254314670135 0.055591357602402 0.9999999999999986 0.1684672106022032 5 P55263 1 |
| Cholesterol biosynthesis pathway 0.6389443756267766 1.874813551624467 0.0608183781932023 1.0 0.181542858906709 11 P48449,Q16850 2 |
| Cholesterol biosynthesis with skeletal dysplasias 0.7572049369576948 1.8529817660569987 0.0638849721952716 1.0 0.1897479024904337 6 Q16850,Q15392,Q14739 3 |
| Proteoglycan biosynthesis 0.6468823845171506 1.8484177113685825 0.0645419384695284 1.0 0.1907501844866758 4 Q8TB61 1 |
| Hair follicle development organogenesis part 2 of 3 0.5868917576961246 1.8385325542692696 0.0659839693864401 1.0 0.1940513779492845 3 Q9BZE4,P35222 2 |
| Wntbetacatenin signaling pathway in leukemia 0.5849056603773544 1.8277381514031257 0.0675888594252338 1.0 0.1977968092003167 3 P48729,P35222 2 |
| Mirnas involvement in the immune response in sepsis 0.5844166075581861 1.8250785185402931 0.067989181337263 1.0 0.1979977622358343 3 Q9Y6K9 1 |
| Rala downstream regulated genes 0.7348225386089859 1.755534101941418 0.079167992838796 1.0 0.2229400553054775 6 Q8IYI6,P16989 2 |
| Mthfr deficiency 0.707091777687166 1.7283044630353812 0.0839336533412675 1.0 0.233062283929008 7 P35790,P26358 2 |
| Reninangiotensinaldosterone system raas 0.5656518896164334 1.7225540473112328 0.0849692010419507 1.0 0.2348454306576137 3 Q13555 1 |
| Oxidative stress response 0.6195695314873914 1.7114927384940166 0.086990190536333 1.0 0.239323243088437 4 P09601 1 |
| Neurodegeneration with brain iron accumulation nbia subtypes pathway 0.6021860605731817 1.675457816452505 0.0938444409925369 1.0 0.2523654561826332 11 P49815,Q99570,O15269,Q13057 4 |
| Aryl hydrocarbon receptor pathway wp2873 0.6031049608794152 1.6282043936724933 0.1034815534766073 1.0 0.2757968188639937 4 Q15185 1 |
| Spinal cord injury 0.5159277415165131 1.577981326286082 0.1145698998530599 1.0 0.3003353042075292 18 P61586,P14174,P08670 3 |
| T cell receptor and costimulatory signaling 0.5930699811952849 1.5771928111390416 0.1147511666246567 1.0 0.3003353042075292 4 P49840,P48729 2 |
| Resistin as a regulator of inflammation 0.6938661031479618 1.5752272716177729 0.1152039944112632 1.0 0.3003353042075292 6 Q9Y6K9,P31751 2 |
| Selenium micronutrient network 0.6064767523887556 1.5684983013914682 0.1167648860664614 1.0 0.301768991262673 10 Q8WTV0,P30044,P32929 3 |
| Nitric oxide metabolism in cystic fibrosis 0.6318906450617713 1.5241204112974576 0.1274786347483458 1.0 0.3221180568797035 5 Q86X55 1 |
| Nephrotic syndrome 0.5501460850360027 1.5231321199400707 0.1277256543649456 1.0 0.3221180568797035 12 Q14108 1 |
| Follicle stimulating hormone fsh signaling pathway 0.6290573979480035 1.5106429112691129 0.1308794547590994 1.0 0.3269248305070392 5 P49815,P28482,P62753 3 |
| Atm signaling in development and disease 0.4728177323493918 1.5023233644100942 0.1330136174243281 1.0 0.3289864036863602 22 P49815,Q9Y6K9,P78527,Q14739 4 |
| Ebola virus infection in host 0.4164983883465702 1.4716747016744194 0.1411087423297574 1.0 0.3438445680443477 36 P10321,O75569,P61586,P41440,P61916,O15118 6 |
| Metapathway biotransformation phase i and ii 0.4736737769912332 1.468752486237718 0.1418999356783126 1.0 0.3443669170729781 21 O14880,O43488,Q7LGA3,Q16850,Q86UY6,P07099,Q8NCH0,P00390 8 |
| Dna repair pathways full network 0.3985467182358189 1.4583698339732147 0.1447386308614637 1.0 0.3498338567785177 44 P27695,P09874,Q9NR33,Q9UQ84,P78527,P09429,P41440,Q9NRF9,P35250 9 |
| Tolllike receptor signaling related to myd88 0.5692825159616168 1.4556237835506152 0.1454966495937673 1.0 0.3499072979440462 4 Q9Y6K9 1 |
| Folatealcohol and cancer pathway hypotheses 0.4665784248841906 1.4527184100515924 0.1463019533008207 1.0 0.3499072979440462 2 P11766 1 |
| Pregnane x receptor pathway 0.5673264897160468 1.4455920980929695 0.1482916442875201 1.0 0.3499072979440462 4 P08183 1 |
| Omega3 omega6 fatty acid synthesis 0.6645543903163934 1.444871925113443 0.1484938635000841 1.0 0.3499072979440462 6 O15254,Q15067 2 |
| Dna replication 0.4373003116482603 1.438239892915396 0.1503659997836877 1.0 0.3506582104330529 28 P28340,O43913,P33991,P12004,Q14566,P49736,Q07864,P09884,P41440,Q9Y619,P35250 11 |
| Heme biosynthesis 0.612677867843148 1.432540717073582 0.1519891340198453 1.0 0.3514374468787428 5 P36551,P22830 2 |
| Transsulfuration pathway 0.6197022919429866 1.4165739785095306 0.1566075208886814 1.0 0.355493117758718 8 P32929,P26358 2 |
| Osteoblast differentiation and related diseases 0.6140603778229117 1.389283776934131 0.1647464750762366 1.0 0.3697505474455386 8 Q05655,O00443,P78527,P28482,Q99570,P27361 6 |
| Extracellular vesiclemediated signaling in recipient cells 0.5042433321187133 1.3815723340795023 0.1671030535968269 1.0 0.3722407574526332 3 Q9NWH9 1 |
| Overlap between signal transduction pathways contributing to lmna laminopathies 0.5117562523820499 1.3670998473436635 0.1715940111354872 1.0 0.3806682218686415 14 O60725,O75844 2 |
| Envelope proteins and their potential roles in edmd physiopathology 0.475248415760236 1.360339010164911 0.1737226689987114 1.0 0.3812957110008483 19 P61586,O75531 2 |
| Interactome of polycomb repressive complex 2 prc2 0.5969603648456736 1.3573474803971808 0.1746708274622468 1.0 0.3819724688460123 5 Q9NYF8,O75530 2 |
| Sulfation biotransformation reaction 0.5483443708609148 1.3480267881877344 0.1776497667892094 1.0 0.3856614937205745 4 P00390,P11413,O95340 3 |
| Target of rapamycin tor signaling 0.5926434446613795 1.336662844053148 0.1813327154851922 1.0 0.3892773256143036 5 P49815 1 |
| Nucleotidebinding oligomerization domain nod pathway 0.6216243549267358 1.3341031494830682 0.1821700538174435 1.0 0.3892773256143036 7 Q9Y6K9,Q7L5N1 2 |
| Alpha 6 beta 4 signaling pathway 0.5825569564430984 1.332866462676784 0.182575630103861 1.0 0.3892773256143036 9 Q05655,P11047,P61586,P28482,Q06124,P27361 6 |
| Pyrimidine metabolism 0.394418362582037 1.2992978939933053 0.1938417168401529 1.0 0.4089169786345276 38 P04183,P62875,P17812,P32321,P28340,P30876,Q9NR33,P04818,Q07864,P09884,P27708,Q9H9Y6,Q9NRF9,Q9H773 14 |
| Hijack of ubiquitination by sarscov2 0.6300468428396235 1.2904752319415198 0.196885706006944 1.0 0.4138759383314984 6 Q15369,Q9C0D3 2 |
| Regulation of apoptosis by parathyroid hormonerelated protein 0.4848641424834211 1.272814710850983 0.2030837997468197 1.0 0.4210180891949846 3 P49840 1 |
| Phosphoinositides metabolism 0.6244596644200945 1.2654240252264972 0.2057193673289812 1.0 0.4249635373543314 6 Q99570,Q01968,Q9Y217 3 |
| Wnt signaling pathway 0.5260718062783997 1.2547082175196882 0.20958470154758 1.0 0.4314554028410526 11 P61586 1 |
| Nucleotide excision repair 0.4430427226139018 1.2491559835155797 0.2116080276729042 1.0 0.4341236856382262 21 Q9NRF9,P35250,Q9NR33,P41440 4 |
| 15q112 copy number variation syndrome 0.5230336621229941 1.217563423208373 0.2233899211270551 1.0 0.4520806200435658 4 Q7L576 1 |
| Allograft rejection 0.5563149930170147 1.1999738669603066 0.2301494899463225 1.0 0.4571110499878977 9 P04439,P10321,P08670,P08183 4 |
| Transsulfuration and onecarbon metabolism 0.4490433239509354 1.1816154823012752 0.2373583075087588 1.0 0.4692149323931425 19 O43865,P26358,P34896,P04818,P32929 5 |
| Interactions between loxl4 and oxidative stress pathway 0.4677916174862134 1.1768864884359145 0.2392408157048682 1.0 0.4706134477713043 3 Q8TAG9 1 |
| Small cell lung cancer 0.5090225817393934 1.1598453738964605 0.2461117666498937 1.0 0.4791955835959321 11 Q9Y6K9,P11047,P11802,P31751,O15111 5 |
| Oxysterols derived from cholesterol 0.5820315554816183 1.1496657617798614 0.2502815612761049 1.0 0.4792840774489459 7 Q9UBM7,Q15125 2 |
| Angiogenesis 0.4172733289212562 1.1491839905193342 0.2504801208778411 1.0 0.4792840774489459 2 P28482 1 |
| Synaptic signaling pathways associated with autism spectrum disorder 0.5947249103209282 1.1321152070197844 0.2575860023493925 1.0 0.4897415394986858 6 P49815 1 |
| Circadian rhythm genes 0.3742531122436727 1.1275399625370992 0.259514254245192 1.0 0.4918413009027925 39 Q03164,P63208,P49327,P23246,Q15233,P00813,P11802,P04818,P78527,Q14103,Q08211,Q9NRV9,P17844,P43490,P62140,Q00839 16 |
| Constitutive androstane receptor pathway 0.5408908014726121 1.0884740113559177 0.2763859034952589 1.0 0.5172488538767072 5 P08183 1 |
| Disruption of postsynaptic signaling by cnv 0.5317500419539891 1.0757241738582657 0.2820506327927903 1.0 0.5262007118040495 9 Q7L576,Q13555 2 |
| Vitamin b12 metabolism 0.5655949301830097 1.073238530392502 0.2831641071351041 1.0 0.526632311400801 7 Q8WTV0 1 |
| Estrogen signaling pathway 0.5366085774354747 1.0679944521002882 0.2855230143679916 1.0 0.5293703092474876 5 Q9Y6K9,P62873,O15111 3 |
| Glycerophospholipid biosynthetic pathway 0.5629643315038838 1.0610297959351431 0.2886763604123314 1.0 0.5313230566214173 7 O00116,Q9HCL2 2 |
| Mfap5mediated ovarian cancer cell motility and invasiveness 0.4468923264926595 1.0596805615049638 0.2892899490461325 1.0 0.5313230566214173 3 P28482 1 |
| Nongenomic actions of 125 dihydroxyvitamin d3 0.5411898147649078 1.0361816854677388 0.3001173893149125 1.0 0.5429396406697053 8 Q13557,Q13555 2 |
| Vitamin d receptor pathway 0.4658930624456358 1.0306005560059452 0.3027281752477166 1.0 0.5443636163339965 12 P09493 1 |
| Chromosomal and microsatellite instability in colorectal cancer 0.4556061517586067 1.0252945482130082 0.305224227421665 1.0 0.5444919192361753 14 Q96KP1,P61586 2 |
| Autophagy 0.5264037571798035 1.0192856509876955 0.3080673741253215 1.0 0.5444919192361753 5 Q99570 1 |
| Primary focal segmental glomerulosclerosis fsgs 0.4316948027757344 1.018802796447162 0.308296597859734 1.0 0.5444919192361753 18 P08670,P11047,Q14108,P46013,P35579 5 |
| Tryptophan metabolism 0.44902875865925 1.0168403827176122 0.3092293679477844 1.0 0.5444919192361753 15 Q16836,Q15392,P40939,Q92947,O94788,Q99873 6 |
| Corticotropinreleasing hormone signaling pathway 0.4387225843714576 0.9866936041468488 0.3237928664636773 1.0 0.5615964464880564 16 P61586,P42892 2 |
| Immune response to tuberculosis 0.3898080741231083 0.9806139174427276 0.3267831685143003 1.0 0.5615964464880564 2 O60244 1 |
| Sars coronavirus and innate immunity 0.3898080741231079 0.9806139174427244 0.3267831685143019 1.0 0.5615964464880564 2 Q7Z434 1 |
| Folate metabolism 0.4438606085043259 0.954338580090366 0.3399122852608327 1.0 0.5797932408591918 14 Q8WTV0,P34896,P32929,P41440 4 |
| Proteasome degradation 0.3516681998415478 0.9464979281587568 0.3438946785049834 1.0 0.5849148805341171 41 P60900,P20618,P10321,P61289,P49721,O75832,P28074 7 |
| Hostpathogen interaction of human coronaviruses interferon induction 0.550375721957967 0.9345603219466468 0.3500149352513904 1.0 0.5936332850712501 6 Q9Y6K9 1 |
| Hif1a and pparg regulation of glycolysis 0.421990239049181 0.9211066111632596 0.3569947689419561 1.0 0.6024906623462042 3 P60174 1 |
| Omega9 fatty acid synthesis 0.5044185208845461 0.9150024322601036 0.3601903532516259 1.0 0.6057285658907626 5 P49327,O95864 2 |
| Cardiac hypertrophic response 0.4439559052019431 0.9035053126779726 0.3662577699154461 1.0 0.6107706386578808 12 Q9Y6K9,P31751,O15111 3 |
| Genes related to primary cilium development based on crispr 0.4609936073506975 0.8945931821231555 0.3710045977501577 1.0 0.6152492912690116 11 A0AVF1,Q10713,P63167 3 |
| Male infertility 0.3846216002904697 0.8898858034669461 0.3735272075673386 1.0 0.6177167393842137 23 P09874,Q8IWV8,Q15165,P08183,P41440 5 |
| Wnt signaling 0.4366308570305315 0.8846495910465203 0.376345651223001 1.0 0.6201831828182331 13 Q13555 1 |
| Sphingolipid metabolism in senescence 0.4746565058167332 0.8734356061095445 0.3824256905599408 1.0 0.6272201573194633 10 P11802,Q06136,P16278,O15269,P28482,P04062 6 |
| Bile acids synthesis and enterohepatic circulation 0.4116940887997687 0.8644207967901473 0.3873567724445443 1.0 0.633567104518885 3 P28482 1 |
| Leptin and adiponectin 0.3692918596955758 0.856294081274127 0.3918351342780228 1.0 0.6384978599540274 2 Q13085 1 |
| Ebsteinbarr virus lmp1 signaling 0.4880147145407543 0.8380444458714433 0.4020057418622844 1.0 0.6439499569133266 5 Q9Y6K9 1 |
| Dna irdouble strand breaks and cellular response via atm 0.3846890459360026 0.8332003209134602 0.4047317616450891 1.0 0.6439499569133266 21 P09874,Q9UQ84,P78527 3 |
| Tcell activation sarscov2 0.4309344753422335 0.82894613135244 0.407134889921108 1.0 0.6439499569133266 12 P49815,Q9Y6K9 2 |
| Apoptosisrelated network due to altered notch3 in ovarian cancer 0.418148378240075 0.8276962310809781 0.4078425541169928 1.0 0.6439499569133266 15 P05067,P16989 2 |
| Tlr4 signaling and tolerance 0.4833448533345072 0.816310873276375 0.4143223570774363 1.0 0.6509222294084986 5 Q9Y6K9 1 |
| Fatty acid betaoxidation 0.3929031951760035 0.8027401834543165 0.4221249220236438 1.0 0.6597083205448045 19 P09622,O43772 2 |
| Alzheimers disease 0.2791253694274343 0.7910657360582924 0.4289056324657001 1.0 0.6685552547833499 81 P60900,P20618,O95197,P68371,P45880,Q92542,P49721,P31751,O15111,P28074,P05067,Q00535,P21796 13 |
| Nucleotide excision repair in xeroderma pigmentosum 0.345459632469478 0.7730223015085977 0.4395091823159422 1.0 0.6762551078417978 31 P09874,P28340,Q9NR33,Q07864,P41440,Q9NRF9,P35250 7 |
| Alzheimers disease and mirna effects 0.278039546814683 0.7667876055352291 0.4432078067860301 1.0 0.6784488734647691 82 P60900,P20618,O95197,P68371,P45880,Q92542,P49721,P31751,O15111,P28074,P05067,Q00535,P21796 13 |
| Kallmann syndrome 0.4330973238250132 0.7601407183529189 0.4471704757077765 1.0 0.6796570740950281 4 Q06124,P28482 2 |
| Dna irdamage and cellular response via atr 0.3388703106785065 0.7579478211317919 0.4484822203803467 1.0 0.6796570740950281 32 P09874,Q9Y6K9,Q9UQ84,P78527 4 |
| Id signaling pathway 0.3527465254798211 0.7578331073433577 0.4485508998215093 1.0 0.6796570740950281 2 P24941 1 |
| Vitamin d in inflammatory diseases 0.4682532701932261 0.7467263520073599 0.4552287595240498 1.0 0.6862449963295184 5 Q9Y6K9,O60244,O15111 3 |
| P53 transcriptional gene network 0.5066459309498607 0.7441399681256966 0.4567918015528387 1.0 0.6862449963295184 6 P49327,Q709F0 2 |
| Neural crest cell migration in cancer 0.4712350314769888 0.7054444453554854 0.4805336930967856 1.0 0.7118576049101266 8 Q99523,P61586,P31751 3 |
| Degradation pathway of sphingolipids including diseases 0.4808808503002063 0.6884941741815152 0.4911416377298789 1.0 0.7239612027768353 7 P06280,O43681,P16278 3 |
| Dna damage response only atm dependent 0.3923491056673772 0.6740300882694413 0.5002921848647506 1.0 0.7302553407439024 15 O00443,P61586,P09429,P60953,P31751,Q99570,Q16822 7 |
| Nrf2 pathway 0.3821208477559157 0.6660867561691096 0.5053556492053863 1.0 0.7358471282332089 17 P09601,Q14914,Q15043 3 |
| Adipogenesis 0.3856652228042199 0.6598084209983334 0.5093767786491381 1.0 0.7398976565779452 16 P43490,P14174 2 |
| Glycosaminoglycan degradation 0.4855606935576075 0.6551559185508873 0.5123673724674467 1.0 0.7424352460268584 6 P15586,P16278 2 |
| Head and neck squamous cell carcinoma 0.4113847549862316 0.6306178706473847 0.5282904111974933 1.0 0.7603594442313195 11 P49815,P31751,P62753 3 |
| Vitamin dsensitive calcium signaling in depression 0.4740582943879832 0.607698763654876 0.5433872831861484 1.0 0.7736996999406912 6 P20020,P00390,O60341,Q8NB78 4 |
| G1 to s cell cycle control 0.3396960496057327 0.5947419617298442 0.5520159681513579 1.0 0.7743905810317699 24 P33993,O43913,P33991,P12004,P11802,Q14566,P24941,P49736,Q07864,P06493,Q9Y619,O75419,P14635 13 |
| Cysteine and methionine catabolism 0.4589727534672074 0.5941977305672139 0.5523798704889393 1.0 0.7743905810317699 7 P23526,P25325,P32929 3 |
| Nrp1triggered signaling pathways in pancreatic cancer 0.4189426228413556 0.5932455136272098 0.5530168572216636 1.0 0.7743905810317699 10 P36507,Q9NWH9,P24941,P49840,P31751,P28482,P27361 7 |
| Regulation of actin cytoskeleton 0.3159466306382251 0.5871401301365099 0.5571095976339335 1.0 0.7752783911129565 37 Q9UQB8 1 |
| Nuclear receptors metapathway 0.3104779427037312 0.5836699182357616 0.5594424097461737 1.0 0.7767142293452689 42 O14880,Q9HCL2,Q15067,P09601,Q14914,P08183,Q15185,Q15043 8 |
| Methylation pathways 0.3947019867549525 0.5761416532010442 0.5645194391527921 1.0 0.7819445595689487 4 Q9NZL9,P51580,P31153 3 |
| Pathogenic escherichia coli infection 0.3417983233815035 0.5622264120589074 0.5739617683440359 1.0 0.7902636415195899 22 O15143,P68371,P07437,P61586,Q9BUF5 5 |
| Cell migration and invasion through p75ntr 0.4265254014011114 0.5614416220187433 0.5744965166155813 1.0 0.7902636415195899 5 P61586 1 |
| Nad metabolism in oncogeneinduced senescence and mitochondrial dysfunctionassociated senescence 0.3764120026422295 0.545040272491641 0.5857258197885788 1.0 0.8010214790270449 13 P43490 1 |
| Histone modifications 0.4082296815553827 0.5421806355642622 0.5876940739015812 1.0 0.8010214790270449 10 Q03164,Q15047,O75530,Q96KQ7 4 |
| G13 signaling pathway 0.365832580263002 0.5231281693145193 0.6008850637947527 1.0 0.809287835476867 15 Q7L576,P61586 2 |
| Novel intracellular components of rigilike receptor rlr pathway 0.3896678920326519 0.5215131627125138 0.6020093385590846 1.0 0.809287835476867 11 Q13526,Q9Y6K9,O15111 3 |
| Modulators of tcr signaling and t cell activation 0.3746911924883149 0.5213833117285994 0.6020997745239931 1.0 0.809287835476867 12 Q15366,Q9Y6K9 2 |
| Kisspeptinkisspeptin receptor system in the ovary 0.4516045807190138 0.5177995312633071 0.6045981454082743 1.0 0.809293930064439 6 Q05655,P27361,P31751,P28482 4 |
| Ampactivated protein kinase ampk signaling 0.370975877541418 0.5022905826207612 0.6154631326736149 1.0 0.8184464777834977 12 P49815,P49327,Q13085,O00763,P13639,P31751 6 |
| Onecarbon metabolism 0.3681349264283035 0.5013575949969047 0.6161194778591634 1.0 0.8184464777834977 13 P34896,P04818,P26358 3 |
| Praderwilli and angelman syndrome 0.4459336217284719 0.4957553496683667 0.6200670307101894 1.0 0.8207982645986321 6 Q7L576,Q15154 2 |
| Sphingolipid metabolism overview 0.4072702668321568 0.4808366746112829 0.6306325824687666 1.0 0.8220254404669295 5 O15269 1 |
| Sphingolipid metabolism integrated pathway 0.4072702668321568 0.4808366746112829 0.6306325824687666 1.0 0.8220254404669295 5 O15269 1 |
| Leptin signaling pathway 0.3165600564965199 0.4599397465809355 0.6455594698342357 1.0 0.8270766133260314 25 P36507,Q13085,Q9Y6K9,P61586,P62753,O00763,P49840,P60953,Q07666,P06730,O15111,P28482,Q06124,P27361 14 |
| Micrornas in cardiomyocyte hypertrophy 0.3317916808665904 0.4478959402818438 0.6542282984351226 1.0 0.8327810110144311 20 P61586,Q9Y6K9,P31751,O15111 4 |
| Type i interferon induction and signaling during sarscov2 infection 0.3243958953988684 0.4183683111786784 0.6756778517410786 1.0 0.8490757984388663 3 Q7Z434,P42224 2 |
| Osteopontin signaling 0.3586486992319807 0.416972464909362 0.6766985481823051 1.0 0.8490757984388663 4 P28482,O15111 2 |
| Nicotine effect on dopaminergic neurons 0.3569395573972309 0.4098635667952816 0.6819060327388486 1.0 0.8516692500943361 4 Q00535 1 |
| Neuroinflammation and glutamatergic signaling 0.3176300881722618 0.3922866302561609 0.6948464411013386 1.0 0.8598043530930688 21 Q13555 1 |
| Cytosolic dnasensing pathway 0.3469845579078292 0.384284202458925 0.7007678154140693 1.0 0.8643768301698335 12 P62875,Q9Y6K9,Q7Z434,Q86UT6,Q9NZI8,O15111,Q14258 7 |
| Type ii diabetes mellitus 0.34745550460774 0.3712560344606794 0.710446841020508 1.0 0.8727093911301302 4 Q05655 1 |
| Apoptosis 0.3689082975987092 0.3669280901942621 0.7136726577317858 1.0 0.8739030266938393 10 Q9Y6K9,O15111 2 |
| Burn wound healing 0.3911831010234372 0.3660253057234177 0.7143461926743611 1.0 0.8739030266938393 8 P07737,P08670 2 |
| Splicing factor nova regulated synaptic proteins 0.3362096527173516 0.3543729831817324 0.7230593788633388 1.0 0.8816239903624608 14 Q13555 1 |
| Ccl18 signaling pathway 0.3739972121586217 0.3412486402476284 0.732916408834386 1.0 0.8868018167340027 9 P08670 1 |
| Nonalcoholic fatty liver disease 0.2784875920968502 0.3367965374507635 0.7362702834585333 1.0 0.8868018167340027 44 Q9Y6M9,P20674,P00403,P08574,P14406,O14949,Q86Y39,P49327,P14854,P22695,O95298,P31751,P31930,O75251,P51970,Q9UDW1 16 |
| Biomarkers for pyrimidine metabolism disorders 0.4006587547911948 0.3318749288533592 0.7399837023540257 1.0 0.8868018167340027 6 P04818 1 |
| Endothelin pathways 0.370473224146333 0.3277367564685172 0.7431107093068423 1.0 0.8868018167340027 9 P42892 1 |
| Biotin metabolism including iems 0.3804638404926617 0.3262958608547748 0.744200519570746 1.0 0.8868018167340027 8 O00763,Q96RQ3 2 |
| Pdgf pathway 0.3285507237997421 0.3183226625846622 0.7502401954281033 1.0 0.890444128569737 14 P61586,P00403 2 |
| Retinoblastoma gene in cancer 0.2710119914306654 0.3097870477769697 0.756722901795106 1.0 0.8911062138079652 47 P26358,Q14566,P04818,P78527,Q16204,P09884,Q9Y619 7 |
| Erbb signaling pathway 0.322685583087885 0.3022985181965514 0.7624245078414327 1.0 0.8911062138079652 15 P31751,Q13555 2 |
| Il18 signaling pathway 0.2648215611112451 0.2999855916119419 0.764188146013139 1.0 0.8911062138079652 50 Q05655,P09874,P49327,Q9HC07,Q6IBW4,Q16836,P39687,Q9UIG0,P13639,P09601,P40939,Q9UMR5,O15111,Q32MZ4,Q9NZJ7,Q07866 16 |
| Physicochemical features and toxicityassociated pathways 0.3218051114315301 0.2982139667029295 0.765539862616132 1.0 0.8911062138079652 15 P07737,P61586 2 |
| Sphingolipid pathway 0.3817415090935812 0.2979721300055538 0.7657244349807137 1.0 0.8911062138079652 7 O95470,P04062,Q06136,O15269 4 |
| Pancreatic adenocarcinoma pathway 0.2949913550739388 0.2756092889518485 0.7828481743562268 1.0 0.9039852226125096 22 P61586,Q9Y6K9,P31751,O15111 4 |
| Neural crest cell migration during development 0.3730695252284439 0.2695865593222323 0.7874783417312545 1.0 0.9075763899875656 7 P61586,P31751 2 |
| Lung fibrosis 0.3762961119549205 0.2546087344788304 0.7990253123381019 1.0 0.9173425220497056 6 P09601 1 |
| Mrna processing 0.2411035277394927 0.247064761259834 0.804858104895712 1.0 0.9215450147835316 105 P52272,Q9UK45,Q9Y333,O00267,Q14103,Q92620,P31943,P62318,Q13243,Q15233,Q5KU26,Q15287,P14866,P55769,Q01130,P38159,Q09161,Q00839,Q15428,Q05048,O43390,Q15366,P62314,P62304,Q9UKA9,Q6P2Q9,P23246,P61978,Q08211,P62316,Q99873,P84103,Q96DI7 33 |
| Dna damage response 0.2888551374205926 0.2333264487252863 0.8155079222025452 1.0 0.9255859877469952 21 P49327,P11802,P06493,P78527,P38398,P41440,Q00535,P14635 8 |
| Mesodermal commitment pathway 0.2899247305173788 0.219885192521447 0.8259605687599454 1.0 0.9270247374371672 20 Q9BYW2,Q13085,Q86XI2,P63173,Q8N3C0,Q8IWS0,Q16204,P10644,Q9UPN3 9 |
| Ciliopathies 0.3007862365810831 0.2068742542466203 0.836108063701748 1.0 0.9330028299625112 15 Q99570,Q10713,O43924 3 |
| Mirna regulation of dna damage response 0.2811732570362807 0.2035459443887897 0.8387083387773433 1.0 0.934158354944168 22 P49327,P33993,P11802,P06493,P24941,P78527,P38398,P41440,P35251,Q00535,P14635 11 |
| Serine metabolism 0.340959042323131 0.159369987732123 0.873377382997766 1.0 0.9480114502721204 6 P34896,P04818 2 |
| Fas ligand pathway and stress induction of heat shock proteins 0.2856547863461804 0.1445956272804914 0.8850301498751876 1.0 0.9533599129718078 14 P09874,P78527 2 |
| Thermogenesis 0.2664949797277715 0.1419308744556268 0.8871346068880075 1.0 0.9533599129718078 23 O43772 1 |
| Tcell antigen receptor tcr pathway during staphylococcus aureus infection 0.2842079849409124 0.1348927714118779 0.8926966548917004 1.0 0.9550894318464964 12 Q9UHD1,Q9Y6K9 2 |
| Fatty acid transporters 0.3004306061609952 0.1310152762388939 0.8957632228793715 1.0 0.9566558927709924 5 O95573,P33121,O60488,Q01469 4 |
| Ras signaling 0.2573623070042334 0.1253432478804152 0.9002518152806176 1.0 0.9580219852451493 27 P61586,Q96KP1,Q9Y6K9,P31751 4 |
| Tolllike receptor signaling pathway 0.2786741902861072 0.1192084274249077 0.905110230142124 1.0 0.96091419052409 13 Q9Y6K9,P31751 2 |
| Urea cycle and metabolism of amino groups 0.3108462909683949 0.1178471629722155 0.9061887592379608 1.0 0.96091419052409 8 P52788,P12277 2 |
| Ranklrank signaling pathway 0.2694093844046158 0.0932141477157173 0.925733435073889 1.0 0.9752623056988704 14 Q9Y6K9,P31751 2 |
| Thyroid hormones production and peripheral downstream signaling effects 0.2668688288007046 0.0852596094063583 0.9320550015903448 1.0 0.9770170799606402 12 P49815,O60341,P62753,Q7LBC6,P28482 5 |
| Cerebral organic acidurias including diseases 0.2728147326629179 0.0763750897739719 0.9391206871892852 1.0 0.9801661717692364 5 Q92947 1 |
| Tcell receptor tcr signaling pathway 0.2594465029318752 0.07208177139962 0.9425368328009264 1.0 0.9820148153266196 17 Q05655,Q9Y6K9,P08670,O15111 4 |
| Fbxl10 enhancement of maperk signaling in diffuse large bcell lymphoma 0.2850334289862216 0.0589123049569337 0.9530219571371584 1.0 0.9867820920727016 7 P28482,P27361,O75530,Q15022 4 |
| Pentose phosphate metabolism 0.2504140443855636 0.0437140280511959 0.9651323571384928 1.0 0.9919222712831404 5 P29401,O95336,P52209,P11413 4 |
| Rett syndrome causing genes 0.2502090715039172 0.0434559353604241 0.9653380898082152 1.0 0.9919222712831404 15 P27695,P49770,Q9UPW6 3 |
| H19 action rbe2f1 signaling and cdkbetacatenin activity 0.2700463883366443 0.0359461694956215 0.9713252817024882 1.0 0.9960452489231804 6 Q16527,Q15648,P06400,P11802,P35222 5 |
| Homologous recombination 0.2531477799867404 0.0193880544731324 0.9845315397683664 1.0 1.0 6 P28340,Q92878,Q9Y2S7,P49959,P27694 5 |
| Preimplantation embryo 0.2530580585863134 0.0191525266452802 0.9847194288964168 1.0 1.0 7 Q92945 1 |
| Atm signaling pathway 0.2341361320695767 0.0095162869596998 0.9924072161589188 1.0 1.0 15 Q9Y6K9,Q14676,P38398,Q12888,P06493,P14635 6 |
| Fragile x syndrome 0.2260517401922449 0.0038812718500467 0.9969032008897412 1.0 1.0 40 P49815,P05067 2 |
|
|
